Literature DB >> 31254431

Psychometric validation of the Chinese version of the Second Victim Experience and Support Tool (C-SVEST).

Jiaojiao Chen1, Qiao Yang2, Qinghua Zhao3, Shuangjiang Zheng4, Mingzhao Xiao1.   

Abstract

AIM: To translate and assess the reliability and validity of the C-SVEST scale.
BACKGROUND: Nurses in patient safety incidents, the second victim, may also be traumatized in Western studies, but there is a lack of relevant researches and validated scales in China.
METHODS: A cross-sectional study of 1,442 nurses in China was conducted with the C-SVEST questionnaire. Raw data were randomly divided into two parts for exploratory factor analysis and confirmatory factor analysis, to evaluate the construct validity. Content validity and reliability were tested by content validity index and Cronbach's α coefficients, respectively.
RESULTS: Six-factor structure was emerged, and it explained 68.62% of the total variance. The good fit of the six-factor model was acceptable, and standardized factor loading ranged from 0.62 to 0.89. Cronbach's α coefficient of the scale was 0.866, and each dimension ranged from 0.713 to 0.896. Content validity index at the scale level was 0.99, and content validity index at the item level was 0.89-1.
CONCLUSIONS: The C-SVEST scale has excellent psychometric properties, which can be applied to measure second victims experience and support level in patient safety incidents. IMPLICATIONS FOR NURSING MANAGEMENT: A reliable and valid instrument is available for leaders to identify the impact of patient safety incidents in nurses, and promote their health through effective interventions.
© 2019 John Wiley & Sons Ltd.

Entities:  

Keywords:  nursing; patient safety; psychometrics; scale

Mesh:

Year:  2019        PMID: 31254431     DOI: 10.1111/jonm.12824

Source DB:  PubMed          Journal:  J Nurs Manag        ISSN: 0966-0429            Impact factor:   3.325


  7 in total

1.  Rumination's Role in Second Victim Nurses' Recovery From Psychological Trauma: A Cross-Sectional Study in China.

Authors:  Lianrong Sun; Juan Deng; Jixin Xu; Xuchun Ye
Journal:  Front Psychol       Date:  2022-05-03

2.  Effect of after action review on safety culture and second victim experience and its implementation in an Irish hospital: A mixed methods study protocol.

Authors:  Siobhán E McCarthy; Theresa Keane; Aisling Walsh; Lisa Mellon; David J Williams; Loretta Jenkins; Catherine Hogan; Cornelia Stuart; Natasha Rafter
Journal:  PLoS One       Date:  2021-11-18       Impact factor: 3.240

3.  Translation and Validation of the Malay Revised Second Victim Experience and Support Tool (M-SVEST-R) among Healthcare Workers in Kelantan, Malaysia.

Authors:  Ahmad Zulfahmi Mohd Kamaruzaman; Mohd Ismail Ibrahim; Ariffin Marzuki Mokhtar; Maizun Mohd Zain; Saiful Nazri Satiman; Najib Majdi Yaacob
Journal:  Int J Environ Res Public Health       Date:  2022-02-11       Impact factor: 3.390

4.  Validation of the German Version of the Moral Injury Symptom and Support Scale for Health Professionals (G-MISS-HP) and Its Correlation to the Second Victim Phenomenon.

Authors:  Milena Trifunovic-Koenig; Reinhard Strametz; Bianka Gerber; Sneha Mantri; Stefan Bushuven
Journal:  Int J Environ Res Public Health       Date:  2022-04-16       Impact factor: 4.614

5.  Feelings of being a second victim among Spanish midwives and obstetricians.

Authors:  Irene Santana-Domínguez; Héctor González-De La Torre; José Verdú-Soriano; Miriam Berenguer-Pérez; Juan José Suárez-Sánchez; Alicia Martín-Martínez
Journal:  Nurs Open       Date:  2022-05-28

6.  Validation of the Turkish version of the second victim experience and Support Tool (T-SVEST).

Authors:  Ayça Koca; Atilla Halil Elhan; Sinan Genç; Ahmet Burak Oğuz; Müge Günalp Eneyli; Onur Polat
Journal:  Heliyon       Date:  2022-09-07

7.  Validation of the German Version of the Second Victim Experience and Support Tool-Revised.

Authors:  Reinhard Strametz; Bianka Siebold; Peter Heistermann; Susanne Haller; Stefan Bushuven
Journal:  J Patient Saf       Date:  2022-04-01       Impact factor: 2.243

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.